drugset / Trial / NCT00002452

A Study on the Safety and Effectiveness of L-756423 Plus Indinavir in HIV-Positive Patients Who Have Previously Taken Indinavir

NCT00002452

Phase 2 Completed 30 enrolled Merck Sharp & Dohme LLC
Treatment

Summary

The purpose of this study is to see if L-756423, an anti-HIV drug, is safe to give with indinavir and if it works well at lowering the level of HIV in the blood (viral load).

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject L-756423 Small molecule 800 mg
Background INDINAVIR ANHYDROUS Other / unclassified 400 mg